M
Michael Goodfellow
Researcher at Newcastle University
Publications - 525
Citations - 43434
Michael Goodfellow is an academic researcher from Newcastle University. The author has contributed to research in topics: Streptomyces & Nocardia. The author has an hindex of 82, co-authored 510 publications receiving 40402 citations. Previous affiliations of Michael Goodfellow include Freeman Hospital & University of Newcastle.
Papers
More filters
Chemotaxonomic Characters and CIassification of Some Nocardiofom Bacteria
TL;DR: The results correlate well with other trends in the taxonomy of nocardioform bacteria and confirm the value of chemotaxonomic characters, especially lipids, in the classification and identification of these organisms.
Journal ArticleDOI
Genoketides A1 (I) and A2 (II), New Octaketides and Biosynthetic Intermediates of Chrysophanol Produced by Streptomyces sp. AK 671.
Hans-Peter Fiedler,Anke Dieter,Tobias A. M. Gulder,Inga Kajahn,Andreas Hamm,Ros Brown,Amanda Jones,Michael Goodfellow,Mueller Werner E G,Gerhard Bringmann +9 more
Journal ArticleDOI
Systematic whole-genome sequencing reveals an unexpected diversity among actinomycetoma pathogens and provides insights into their antibacterial susceptibilities
Andrew K Watson,Bernhard Kepplinger,Sahar Mubarak Bakhiet,Nagwa Adam Mhmoud,Michael Goodfellow,Ahmed H. Fahal,Jeff Errington +6 more
TL;DR: All isolates had a high level of resistance against the current first-line antibiotics used to treat actinomycetoma under laboratory conditions, suggesting that alternative agents, such as amikacin, should be considered for more effective treatment.
Journal ArticleDOI
Donor Liver Blood Tests and Liver Transplant Outcomes: UK Registry Cohort Study.
Samuel J Tingle,R. Bramley,Michael Goodfellow,Emily R Thompson,Stuart McPherson,Steven A. White,Colin H Wilson +6 more
TL;DR: In this article , the authors investigated the impact of donor transaminase levels on transplant outcomes and found that transaminases did not predict graft survival, primary nonfunction, 90-d graft loss, or mortality.
Journal ArticleDOI
The diagnostic yield of head and neck imaging in symptomatic patients with a normal clinical examination
TL;DR: In patients with unilateral otalgia and no history of Head and Neck Cancer (HNC), 1% had a malignancy detected on imaging that was not detected on clinical examination.